Evidence map›Paper›PMID 21602213›Full record

ArticleMicrobiology (Reading, England)2011

BgaA acts as an adhesin to mediate attachment of some pneumococcal strains to human epithelial cells.

Dominique H Limoli, Julie A Sladek, Lindsey A Fuller, Anirudh K Singh, Samantha J King

Open access · hybridAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Role ofFrontiers in cellular and infection microbiology · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Panel 4: Report of the Microbiology Panel.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2017
    Review
  18. Article
  19. Article
  20. Role ofFrontiers in microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dominique H LimoliCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, OH 43205, USA.
Julie A SladekThe Ohio State University College of Medicine, Columbus, OH 43210, USA.
Lindsey A FullerCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, OH 43205, USA.
Anirudh K SinghCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, OH 43205, USA.
Samantha J KingThe Ohio State University College of Medicine, Columbus, OH 43210, USA.
Nationwide Children's Hospital · US

Funding

Mechanisms of Pneumococcal AdherenceR01AI076341 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KING, SAMANTHA JANE · 2009 to 2012
$1.3M
NIAID NIH HHS R01 AI076341NIAID NIH HHS R01AI076341-02
6 · The paper itself

Abstract

Streptococcus pneumoniae colonization of the respiratory tract is an essential precursor for pneumococcal disease. To colonize efficiently, bacteria must adhere to the epithelial-cell surface. S. pneumoniae possesses surface-associated exoglycosidases that are capable of sequentially deglycosylating human glycans. Two exoglycosidases, neuraminidase (NanA) and β-galactosidase (BgaA), have previously been shown to contribute to S. pneumoniae adherence to human epithelial cells, as deletion of either of these genes results in reduced adherence. It has been suggested that these enzymes may modulate adherence by cleaving sugars to reveal a receptor on host cells. Pretreatment of epithelial cells with exogenous neuraminidase restores the adherence of a nanA mutant, whereas pretreatment with β-galactosidase does not restore the adherence of a bgaA mutant. These data suggest that BgaA may not function to reveal a receptor, and implicate an alternative role for BgaA in adherence. Here we demonstrate that β-galactosidase activity is not required for BgaA-mediated adherence. Addition of recombinant BgaA (rBgaA) to adherence assays and pretreatment of epithelial cells with rBgaA both significantly reduced the level of adherence of the parental strain, but not the BgaA mutant. One possible explanation of these data is that BgaA is acting as an adhesin and that rBgaA is binding to the receptor, preventing bacterial binding. A bead-binding assay demonstrated that BgaA can bind directly to human epithelial cells, supporting the hypothesis that BgaA is an adhesin. Preliminary characterization of the epithelial-cell receptor suggests that it is a glycan in the context of a glycosphingolipid. To further establish the relevance of this adherence mechanism, we demonstrated that BgaA-mediated adherence contributed to adherence of a recent clinical isolate to primary human epithelial cells. Together, these data suggest a novel role for BgaA as an adhesin and suggest that this mechanism could contribute to adherence of at least some pneumococcal strains in vivo.

Indexed as

Bacterial AdhesionAdhesins, Bacterialbeta-GalactosidaseCells, CulturedEpithelial CellsHumansPolysaccharidesStreptococcus pneumoniaeAdhesins, Bacterialbeta-GalactosidasePolysaccharides

Identifiers

PMID21602213
PMCPMC3167885
OpenAlexW2103650181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.